威高股份(01066.HK)擬1792萬美元以對合約進行約務更替
格隆匯12月29日丨威高股份(01066.HK)公佈,於2020年12月29日,公司及該附屬公司威高國際醫療有限公司與威高集團公司就出售事項及約務更替訂立該等協議。該附屬公司已同意出售,而威高集團公司已同意購買票據。於轉讓協議日期,尚未償還的票據本金額為4008.4萬美元。票據為不計息可換股票據,於2022年12月31日可轉換為NeuroVasc的85%全面攤薄普通股。出售事項的代價為4694萬美元,其將於威高集團公司完成有關票據投資的相關監管註冊要求後支付,其須於2021年4月30日前進行。
此外,公司與威高集團公司已同意按代價1792萬美元以對該等合約進行約務更替,其將由威高集團公司於2021年1月31日前支付。於約務更替完成後,該等合約的所有責任及利益將轉移至威高集團公司。作為出售事項的一部分,該附屬公司與威高集團公司已同意根據第二份約務更替協議對該抵押進行約務更替。該抵押原本由Neuro Vasc就該附屬公司認購票據而向該附屬公司授出,以確保Neuro Vasc於票據項下的履約責任。
於出售事項及約務更替完成後,公司預期將錄得收益約788.8萬美元。由於公司對Neuro Vasc的腦部取栓支架業務抱持樂觀態度,因此於2019年年中對其進行投資。作為集團業務產品供應的持續檢討及改進的一部分,並考慮到Neuro Vasc取得研發產品相關許可證的所需時間,公司遂決定撤出其投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.